GlassScriptPhysician profile
Rajiv Ahuja
NPI 1962460782
$12,223.01
in general payments reported to CMS, 2019-2025
45 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,435 · 2020: $1,628 · 2021: $2,273 · 2022: $1,950 · 2023: $1,511 · 2024: $1,616 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,937.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,153.96 | 2019-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $861.45 | 2019-2025 | Verquvo, Steglatro, Belsomra |
| Astrazeneca Pharmaceuticals LP | $857.10 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $740.67 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $580.48 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $562.97 | 2019-2023 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $547.41 | 2022-2025 | Zoryve |
| Pfizer INC. | $489.06 | 2019-2024 | |
| Lilly USA, LLC | $478.95 | 2020-2025 | Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $472.52 | 2019-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $441.41 | 2019-2025 | |
| Amarin Pharma, INC. | $434.72 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $415.19 | 2021-2025 | |
| Vbi Vaccine (Delaware) INC. | $340.99 | 2022-2023 | Prehevbrio |
| E.R. Squibb & Sons, L.L.C. | $271.10 | 2019-2023 | Camzyos |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.